The Department of Science and Technology (DOST) welcomes the news of another COVID-19 vaccine applying for Emergency Use Authorization (EUA) in the Philippines. One good thing is that Janssen Pharmaceuticals did clinical trials in the Philippines, the results of which only the vaccine developing company can announce.
More vaccines with EUA approved by the Food and Drug Administration Philippines (FDA) means more vaccines can enter the country adding to the adequacy of supply.
The DOST is involved in vaccine evaluation prior to clinical trials where our FDA is also the approving authority, particularly through DOST’s Vaccine Expert Panel (VEP). The FDA can also tap the services of the VEP in processing EUA applications.
